BiotechTube
Home/MipSalus/Nicolas O. Krogh
NO

Nicolas O. Krogh

Chief Executive Officer

MipSalus

Therapeutic Areas

Metabolic DisordersRare Diseases

MipSalus Pipeline

DrugIndicationPhase
Phenylalanine-binding MIPHyperphenylalaninemia (HPA), including Phenylketonuria (PKU)Pre-clinical

Leadership Team at MipSalus

KG
Klaus Gregorius
Chief Scientific Officer
AA
Amanda Andresen
Chief Operating Officer
View full MipSalus profile